[1] 潘大彬, 汪旻晖, 曹蘅. 糖尿病心肌病发病机制的研究进展
[J]. 中国临床药理学与治疗学, 2013, 18(7):831-836.
[2] Trachanas K, Sideris S, Aggeli C, et al. Diabetic
cardiomyopathy: from pathophysiology to treatment[J].
Hellenic J Cardiol, 2014, 55(5):411-421.
[3] Kimura H. Hydrogen sulfide and polysulfides as signaling
molecules[J]. Proc Jpn Acad Ser B Phys Biol Sci, 2015,
91(4):131-159.
[4] Wang YZ, Ngowi EE, Wang D, et al. The potential of
hydrogen sulfide donors in treating cardiovascular diseases[J].
Int J Mol Sci, 2021, 22(4):2194.
[5] Kimura H. Production and physiological effects of Hydrogen
sulfide[J]. Antioxid Redox Signal, 2014, 20(5):783-793.
[6] Zheng W, Liu C. The cystathionine γ-lyase/Hydrogen sulfide
pathway mediates the trimetazidine-induced protection of
H9c2 cells against hypoxia/reoxygenation-induced apoptosis
and oxidative stress[J]. Anatol J Cardiol, 2019, 22(3):102-111.
[7] Zhou X, An G, Lu X. Hydrogen sulfide attenuates the
development of diabetic cardiomyopathy[J]. Clin Sci (Lond),
2015, 128(5):325-335.
[8] Wild S, Roglic G, Green A, et al. Global prevalence of
diabetes: estimates for the year 2000 and projections for
2030[J]. Diabetes Care, 2004, 27(5):1047-1053.
[9] Boudina S, Abel ED. Diabetic cardiomyopathy revisited[J].
Circulation, 2007, 115(25):3213-3223.
[10] Falc?o-Pires I, Leite-Moreira AF. Diabetic cardiomyopathy:
understanding the molecular and cellular basis to progress in
diagnosis and treatment[J]. Heart Fail Rev, 2012, 17(3):325-
344.
[11] Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of
cardiomyopathy associated with diabetic glomerulosclerosis[J].
Am J Cardiol, 1972, 30(6):595-602.
[12] Fan D, Takawale A, Lee J, et al. Cardiac fibroblasts, fibrosis
and extracellular matrix remodeling in heart disease[J].
Fibrogenesis Tissue Repair, 2012, 5(1):15.
[13] Kong P, Christia P, Frangogiannis NG. The pathogenesis of
cardiac fibrosis[J]. Cell Mol Life Sci, 2014, 71(4):549-574.
[14] 杨琼, 吴永全. 内质网应激与糖尿病心肌纤维化[J]. 心脏杂
志, 2014, 26(1):91-93.
[15] Kalachev AV, Yurchenko OV. Microautophagy in nutritive
phagocytes of sea urchins[J]. Protoplasma, 2017, 254(1):609-
614.
[16] Lawrence J, Nho R. The Role of the Mammalian target of
rapamycin (mTOR) in pulmonary fibrosis[J]. Int J Mol Sci,
2018, 19(3):778.
[17] Glick D, Barth S, Macleod KF. Autophagy: cellular and
molecular mechanisms[J]. J Pathol, 2010, 221(1):3-12.
[18] Kirkin V, Mcewan DG, Novak I, et al. A role for ubiquitin in
selective autophagy[J]. Mol Cell, 2009, 34(3):259-269.
[19] Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective
degradation of mitochondria by mitophagy[J]. Arch Biochem
Biophys, 2007, 462(2):245-253.